Bcl-2-IN-21
Bcl-2-IN-21 (compound C1) is an iridium compound with anticancer activity that targets and inhibits Bcl-2. Bcl-2-IN-21 inhibits colony formation of cancer cells and induces elevated levels of Bax and caspase 3[1].
Product Specifications
UNSPSC
12352005
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcl-2-in-21.html
Smiles
FP(F)(F)(F)(F)F.C1(C=CC=C2)=[N]2[Ir]34([N]5=C(C6=[N]4C(C=CC=C7)=C7N6CC8=CC=CC=C8)C=CC9=CC=CC=C59)([N]%10=C(C=CC=C%10)C%11=CC=CC=C%113)C%12=CC=CC=C1%12
Molecular Formula
C45H33F6IrN5P
Molecular Weight
980.96
References & Citations
[1]New cyclometalated iridium (III) complexes bearing substituted 2- (1H-benzimidazol-2-yl) quinoline: Synthesis, characterization, electrochemical and anticancer studies
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog